Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|September 5, 2013
Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitroDarren M Moss, Neill J Liptrott, Paul Curley, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 19, 2010
HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditionsAntonio D'Avolio, Marco Simiele, Marco Siccardi, et al.
Antiviral Therapy|August 23, 2012
Efavirenz in an obese HIV-infected patient--a report and an in vitro-in vivo extrapolation model indicate risk of underdosingMirjam de Roche, Marco Siccardi, Marcel Stoeckle, et al.
Therapeutic Delivery|January 25, 2013
Nanomedicines for HIV therapyMarco Siccardi, Philip Martin, Tom O McDonald, et al.
Molecular Pharmaceutics|September 9, 2015
Augmented Inhibition of CYP3A4 in Human Primary Hepatocytes by Ritonavir Solid Drug NanoparticlesPhilip Martin, Marco Giardiello, Tom O McDonald, et al.
Therapeutic Drug Monitoring|November 23, 2012
Correlates of efavirenz exposure in Chilean patients affected with human immunodeficiency virus reveals a novel association with a polymorphism in the constitutive androstane receptorClaudia P Cortes, Marco Siccardi, Ammara Chaikan, et al.
Clinical Pharmacokinetics|March 13, 2013
Prediction of drug-drug interactions between various antidepressants and efavirenz or boosted protease inhibitors using a physiologically based pharmacokinetic modelling approachMarco Siccardi, Catia Marzolini, Kay Seden, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2018
Effect of Pregnancy on the Pharmacokinetic Interaction between Efavirenz and Lumefantrine in HIV-Malaria CoinfectionAdebanjo Adegbola, Rana Abutaima, Adeniyi Olagunju, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Use of a physiologically based pharmacokinetic model to simulate drug-drug interactions between antineoplastic and antiretroviral drugsJosé Moltó, Rajith Rajoli, David Back, et al.
The Journal of Infectious Diseases|December 20, 2018
Predicting Drug-Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic ModelingRajith K R Rajoli, Paul Curley, Justin Chiong, et al.
Pageof 13